A Study of Lasmiditan in Participants With Migraine

Clinical trial NCT03247790 · COMPLETED

Trial details

NCT number: NCT03247790
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2017-08-16
Primary completion: 2018-01-15
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.